These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 29033897)

  • 1. Evaluation of Cardiometabolic Parameters among Obese Women Using Oral Contraceptives.
    Ferreira JRD; Aleluia MM; Figueiredo CVB; Vieira LCL; Santiago RP; da Guarda CC; Barbosa CG; Oliveira RR; Adorno EV; Gonçalves MS
    Front Endocrinol (Lausanne); 2017; 8():256. PubMed ID: 29033897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contraceptive methods and risk factors of cardiovascular diseases in Tehranian women: Tehran Lipid and Glucose Study.
    Azizi F; Ainy E; Mirmiran P; Habibian S
    Eur J Contracept Reprod Health Care; 2002 Mar; 7(1):1-6. PubMed ID: 12041858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.
    Godsland IF; Crook D; Simpson R; Proudler T; Felton C; Lees B; Anyaoku V; Devenport M; Wynn V
    N Engl J Med; 1990 Nov; 323(20):1375-81. PubMed ID: 2146499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevation of Oxidized Lipoprotein of Low Density in Users of Combined Oral Contraceptives.
    Santos ACND; Petto J; Diogo DP; Seixas CR; Souza LH; Araújo WS; Ladeia AMT
    Arq Bras Cardiol; 2018 Dec; 111(6):764-770. PubMed ID: 30328945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adiponectin, leptin and lipid profiles evaluation in oral contraceptive pill consumers.
    Fallah S; Sanjary Pour M; Rabbani Chadegani A; Korani M
    Arch Gynecol Obstet; 2012 Jun; 285(6):1747-52. PubMed ID: 22210292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relationship between serum high-sensitivity C-reactive protein and obesity and impaired glycose metabolism in children and adolescents].
    Yang SP; Gong CX; Cao BY; Yan C
    Zhonghua Er Ke Za Zhi; 2006 Dec; 44(12):933-6. PubMed ID: 17254464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of third-generation oral contraceptives on high-sensitivity C-reactive protein and homocysteine in young women.
    Cauci S; Di Santolo M; Culhane JF; Stel G; Gonano F; Guaschino S
    Obstet Gynecol; 2008 Apr; 111(4):857-64. PubMed ID: 18378744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of metabolic and inflammatory outcomes in women who used oral contraceptives and the levonorgestrel-releasing intrauterine device in a general population.
    Morin-Papunen L; Martikainen H; McCarthy MI; Franks S; Sovio U; Hartikainen AL; Ruokonen A; Leinonen M; Laitinen J; Järvelin MR; Pouta A
    Am J Obstet Gynecol; 2008 Nov; 199(5):529.e1-529.e10. PubMed ID: 18533124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory cardiovascular risk markers in women with hypopituitarism.
    Sesmilo G; Miller KK; Hayden D; Klibanski A
    J Clin Endocrinol Metab; 2001 Dec; 86(12):5774-81. PubMed ID: 11739438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral, transdermal and vaginal combined contraceptives induce an increase in markers of chronic inflammation and impair insulin sensitivity in young healthy normal-weight women: a randomized study.
    Piltonen T; Puurunen J; Hedberg P; Ruokonen A; Mutt SJ; Herzig KH; Nissinen A; Morin-Papunen L; Tapanainen JS
    Hum Reprod; 2012 Oct; 27(10):3046-56. PubMed ID: 22811306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low insulin-like growth factor 1 is associated with low high-density lipoprotein cholesterol and metabolic syndrome in Chinese nondiabetic obese children and adolescents: a cross-sectional study.
    Liang S; Hu Y; Liu C; Qi J; Li G
    Lipids Health Dis; 2016 Jun; 15():112. PubMed ID: 27343122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoprotegerin in relation to body weight, lipid parameters insulin sensitivity, adipocytokines, and C-reactive protein in obese and non-obese young individuals: results from both cross-sectional and interventional study.
    Gannagé-Yared MH; Yaghi C; Habre B; Khalife S; Noun R; Germanos-Haddad M; Trak-Smayra V
    Eur J Endocrinol; 2008 Mar; 158(3):353-9. PubMed ID: 18299469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex differences in serum leptin and its relation to markers of cardiometabolic risk in middle-aged adults: evidence from a population-based study.
    de Castro MA; Baltar VT; Marchioni DM; Fisberg RM
    Nutrition; 2015 Mar; 31(3):491-7. PubMed ID: 25701340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Both a combined oral contraceptive and depot medroxyprogesterone acetate impair endothelial function in young women.
    Lizarelli PM; Martins WP; Vieira CS; Soares GM; Franceschini SA; Ferriani RA; Patta MC
    Contraception; 2009 Jan; 79(1):35-40. PubMed ID: 19041439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atherogenic and cardiovascular risks of women on combined oral contraceptives: A comparative study.
    Jimoh OS; Abdul IF; Balogun OR; Biliaminu SA; Adeniran AS; Jimoh-Abdulghaffaar HO; Adesina KT; Ahmed A; Oladosu WO
    Niger J Clin Pract; 2021 Dec; 24(12):1759-1765. PubMed ID: 34889782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrasonographic and laboratory markers of metabolic and cardiovascular disease risk in obese women with polycystic ovary syndrome.
    Zueff LF; Martins WP; Vieira CS; Ferriani RA
    Ultrasound Obstet Gynecol; 2012 Mar; 39(3):341-7. PubMed ID: 21898634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered composition of high density lipoproteins in women with the polycystic ovary syndrome.
    Rajkhowa M; Neary RH; Kumpatla P; Game FL; Jones PW; Obhrai MS; Clayton RN
    J Clin Endocrinol Metab; 1997 Oct; 82(10):3389-94. PubMed ID: 9329374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deterioration in cardiometabolic risk markers in obese women during depot medroxyprogesterone acetate use.
    Segall-Gutierrez P; Xiang AH; Watanabe RM; Trigo E; Stanczyk FZ; Liu X; Jurow R; Buchanan TA
    Contraception; 2012 Jan; 85(1):36-41. PubMed ID: 22067800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevalence of hyperlipidemia in women and its association with use of oral contraceptives, sex hormone replacement therapy and nonlipid coronary artery disease risk factors. Canadian Heart Health Surveys Research Group.
    Connelly PW; Stachenko S; MacLean DR; Petrasovits A; Little JA
    Can J Cardiol; 1999 Apr; 15(4):419-27. PubMed ID: 10322251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.